Physician
Neurology
Dr. Stephen M. Sagar, MD
|
|
Give Review
Stephen M. Sagar is an expert in the field of Neurology. He studied medicine at Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1 in research and 12 in primary care medicine Stephen M. Sagar is also published. He has 87 publications published. The lastest publication: "HIV-1 gp120 envelope protein and morphine-tubular cell interaction products modulate kidney fibroblast proliferation.'
Publications
- Phase II Trial of Radiosurgery to Magnetic Resonance Spectroscopy-Defined High-Risk Tumor Volumes in Patients With Glioblastoma Multiforme.
- Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer.
- Systems Modeling in Integrative Oncology.
- Vigabatrin for the treatment of infantile spasms: final report of a randomized trial.
- Can the therapeutic gain of radiotherapy be increased by concurrent administration of Asian botanicals?
- The role of integrative oncology in a tertiary prevention survivorship program.
- Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
- Acupuncture as an evidence-based option for symptom control in cancer patients.
- Future directions for research on Silybum marianum for cancer patients.
- Targeting angiogenesis with integrative cancer therapies.
- A case of multiple meningioma and myotonic dystrophy.
- A Phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients tr...
- Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity.
- Integrative tumor board: recently diagnosed lung cancer.
- Carcinomatous Meningitis: it does not have to be a death sentence.
- HIV-1 gp120 envelope protein and morphine-tubular cell interaction products modulate kidney fibroblast proliferation.
- Morphine modulates mesangial immunoglobulin G uptake in rats with antithymocyte serum-induced mesangial cell injury.
- Simulated glomerular pressure modulates mesangial cell 72 kDa metalloproteinase activity.
- Glomerular metalloprotease activity modulates the development of focal segmental glomerulosclerosis.
- Human immunodeficiency virus-1 gp120 and gp160 envelope proteins modulate mesangial cell gelatinolytic activity.
- Vasoactive agents modulate matrix metalloproteinase-2 activity by mesangial cells.
- Tumour blood flow: measurement and manipulation for therapeutic gain.
- A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
- Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics.
- Somatostatin-like immunoreactive material in the rabbit retina: immunohistochemical staining using monoclonal antibodies.
- Differential expression of immediate early genes in the superior cervical ganglion after nicotine treatment.
- The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom control.
- Epidermal growth factor and transforming growth factor alpha induce c-fos gene expression in retinal Muller cells in vivo.
- Vasoactive intestinal polypeptide (VIP) immunohistochemistry in the rabbit retina.
- Somatostatin-like immunoreactive material in associational ganglion cells of human retina.
- Cephalosporin prophylaxis in abdominal surgery.
- Comparative evaluation of cefotaxime and cephamandole in the prevention of post-operative infective complications following emergency abdominal surgery.
- Integrative oncology: a Canadian and international perspective.
- The integrative oncology supplement--a paradigm for both patient care and communication.
- Extensive S aureus spinal epidural empyema.
- MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex.
- Peripheral neuropathy, high serum IgM, and paraproteinemia in mother and son.
- Olfactory sensations produced by high-energy photon irradiation of the olfactory receptor mucosa in humans.
- Alternative views on alternative therapies.
- Nitric oxide and anti-cancer therapy.
- Alterations in gene expression as an index of neuronal injury: heat shock and the immediate early gene response.
- A rare case of life-threatening penetrating oropharyngeal trauma caused by toothbrush in a child.
- Implications of neuropeptides in neurological diseases.
- A comparison of the effects of kainic acid on somatostatin, substance P and dopamine in the rabbit retina.
- Somatostatin is increased in the basal ganglia in Huntington disease.
- The effect of cysteamine on immunoreactive somatostatin in the rabbit retina.
- The effects of cysteamine on thyrotropin and immunoreactive beta-endorphin secretion in the rat.
- Cysteamine effects on growth hormone secretion in the male rat.
- Somatostatin-like immunoreactive material in the rabbit retina.
- Temporal patterns of somatostatin immunoreactivity in the cerebrospinal fluid of the rhesus monkey: effect of environmental lighting.
- Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine.
- Characterization and regional distribution of calcitonin binding sites in the rat brain.
- Light-dark entrainment of the growth hormone ultradian rhythm in the rat is mediated by the arcuate nucleus.
- Cysteamine: a potent and specific depletor of pituitary prolactin.
- Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary.
- Cysteamine depletes prolactin in young and old hyperprolactinemic rats.
- Cysteamine reduces serum gonadotropin concentrations in adult male rats.
- Cysteamine induces depletion of both immunological and biological prolactin activity in the anterior pituitary and blood of the rat.
- Cysteamine depletes prolactin (PRL) but does not alter the structure of PRL-containing granules in the anterior pituitary.
- The mechanism of action of cysteamine in depleting prolactin immunoreactivity.
- Cysteamine-induced depletion of somatostatin and prolactin.
- The effects of stress on oncology staff.
- The changing role of hospital consultants.
- Evidence based medicine. No guidance is provided for situations for which evidence is lacking.
- Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor.
- Treatment of superficial thrombophlebitis: a randomized, bouble-blind trial of heparinoid cream.
- A clinical audit of glottic cancer in Nova Scotia: a paradigm for effectiveness research.
- How do we evaluate outcome in an integrative oncology program?
- Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2.
- Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1.
- Chinese medicine and biomodulation in cancer patients--Part one.
- Integration of Chinese medicine into supportive cancer care: a modern role for an ancient tradition.
- Massage therapy for cancer patients: a reciprocal relationship between body and mind.
- Research and regulatory issues for integrative oncology.
- Selenium and lung cancer: a systematic review and meta analysis.
- Vitamin A and retinoid derivatives for lung cancer: a systematic review and meta analysis.
- Oral toxicity of vigabatrin in immature rats: characterization of intramyelinic edema.
- Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals.
- Integrative tumor board: Advanced breast cancer.
- Integrative Oncology Practice Guidelines.
- Acupuncture treatment for chemotherapy-induced peripheral neuropathy--a case series.
- Integrative oncology in North America.
- Research on therapeutic massage for cancer patients: potential biologic mechanisms.
- Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals (2009).
- Phase II Randomized Trial of Acupuncture-Like Transcutaneous Electrical Nerve Stimulation to Prevent Radiation-Induced Xerostomia in Head and Neck Cancer Patients.
- Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy.
Schools
Harvard Medical School
Peter Bent Brigham Hospital
Massachusetts General Hospital
Chldns Hospital Med Center
Doctors Specialties
- Internal Medicine
- Neurology
Accepted Insurances
Education
-
Massachusetts General Hospital -
Brigham and Women's Hospital -
Harvard Medical School
Helpful Reviews
Similar Doctors
|
|
Dr. John J. Plucinsky, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Cynthia K. Potter, RN |
|
|
Dr. Judah R. Lindenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Svetlana Pundik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John H. Ferguson, MD |